Thioridazine hydrochloride NEW
| Price | $36 | $48 | $81 |
| Package | 50mg | 100mg | 500mg |
| Min. Order: | |
| Supply Ability: | 10g |
| Update Time: | 2025-12-03 |
Product Details
| Product Name: Thioridazine hydrochloride | CAS No.: 130-61-0 |
| Purity: 99.96% | Supply Ability: 10g |
| Release date: 2025/12/03 |
Product Introduction
Bioactivity
| Name | Thioridazine hydrochloride |
| Description | Thioridazine hydrochloride (Mellaril) , an antipsychotic drug, is used in the therapy of psychosis and schizophrenia and shows serotonin antagonism or D4 selectivity. |
| Storage | store under nitrogen | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Solubility Information | DMSO : 55 mg/mL (135.12 mM), Sonication is recommended. 10% DMSO+40% PEG300+5% Tween 80+45% Saline : 2 mg/mL (4.91 mM), Sonication is recommended. |
| Keywords | Thioridazine hydrochloride | Thioridazine Hydrochloride | Thioridazine | Serotonin Receptor | PotassiumChannel | Potassium Channel | PI3K | mTOR | Inhibitor | inhibit | DopamineReceptor | Dopamine Receptor | Dopamine | CSC | cancer | Bacterial | Autophagy | Apoptosis | antipsychotic | antianxiety | Akt | AdrenergicReceptor | Adrenergic Receptor | 5-hydroxytryptamine Receptor | 5HTReceptor | 5-HT Receptor | 5HT Receptor | 5-HT |
| Inhibitors Related | Neomycin sulfate | Aceglutamide | Adipic dihydrazide | Levulinic acid | D(+)-Raffinose pentahydrate | Sulfamethoxazole sodium | Terbinafine hydrochloride | Hydroxychloroquine | Paeonol | Dimethyl sulfoxide | Sodium diacetate | BES |
| Related Compound Libraries | Failed Clinical Trials Compound Library | Anti-Neurodegenerative Disease Compound Library | Pain-Related Compound Library | Membrane Protein-targeted Compound Library | Anti-Cancer Clinical Compound Library | Drug Repurposing Compound Library | Inhibitor Library | FDA-Approved Drug Library | Bioactive Compounds Library Max | GPCR Compound Library | Anti-Cancer Drug Library | Anti-Cancer Active Compound Library |
Company Profile Introduction
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
You may like
Recommended supplier
| Product name | Price | Suppliers | Update time | |
|---|---|---|---|---|
| $36.00/50mg |
VIP4Y
|
TargetMol Chemicals Inc.
|
2025-12-03 | |
| $81.00/500mg |
VIP2Y
|
TargetMol Chemicals Inc.
|
2025-05-01 | |
| $200.00/10g |
Wuhan Qiami Technology Co., Ltd
|
2022-07-15 | ||
| $1.10/1g |
VIP5Y
|
Dideu Industries Group Limited
|
2021-07-23 | |
| $8.00/1kg |
VIP8Y
|
Career Henan Chemical Co
|
2018-12-21 |
United States- Since: 2011-01-07
- Address: 36 Washington Street, Wellesley Hill, MA
INQUIRY